Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
VanderWeele, David
Associate Professor
Bio
Cancer heterogeneity and evolution with a goal of identifying and targeting drivers of cancer progression and therapy resistance. His research has described intrafocal heterogeneity in prostate cancer... [more]